跳至主要内容
临床试验/ACTRN12624000072516
ACTRN12624000072516招募中Unknown

Australian IntraCranial Hemorrhage Registry - A study to assess current management, adherence to national guidelines and patient outcomes in adults who have suffered an intracranial hemorrhage, including spontaneous non-traumatic intracerebral hemorrhage, non-penetrative traumatic hemorrhage, and anticoagulant-associated intracranial hemorrhage.

The University of New South Wales (UNSW)0 个研究点目标入组 1,500 人开始时间: 2024年1月29日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Age 18 years or older
  • 2. Radiographically confirmed intracranial hemorrhage (intracerebral,
  • intraventricular, subarachnoid or subdural) either spontaneous or
  • 3. If SDH or SAH, patients must also be currently treated with an OAC
  • (VKA, rivaroxaban, apixaban, dabigatran).
  • 4. Time from symptom onset (or last known well) less than 24 hours prior to
  • the baseline imaging scan.

排除标准

  • 1. Penetrating intracranial injury (other traumatic intracranial
  • haemorrhage is eligible).
  • 2. Haemorrhagic transformation of an ischaemic infarct.
  • 3. Haemorrhage secondary to cerebral venous sinus thrombosis.

研究者

发起方
The University of New South Wales (UNSW)

相似试验